Skip to main content
Premium Trial:

Request an Annual Quote

SurroMed, Lilly Launch Biomarker Partnership

NEW YORK, Sept. 3-SurroMed has launched a research collaboration with Eli Lilly to identify new biomarkers, the company said today.

 

Lilly will supply biological samples, which SurroMed will analyze using its mass spectrometry-based platform.

 

The collaboration is broad, seeking to identify biomarkers that are relevant to drug development and disease progression.

 

Financial details of the agreement were not revealed.

 

SurroMed is based in Mountain View, Calif.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.